T1	LIVB 21 29	Paciente
#1	AnnotatorNotes T1	C0030705; Patients; Patient or Disabled Group
T2	PROC 45 53	consulta
#2	AnnotatorNotes T2	C0009818; Consultation; Health Care Activity
T3	PROC 80 87	control
#3	AnnotatorNotes T3	C1522577; follow-up; Health Care Activity
T4	DISO 101 111	patologías
#4	AnnotatorNotes T4	C0677042; Pathology processes; Pathologic Function
T5	LIVB 133 138	Varón
T6	Age 142 149	55 años
T7	DISO 151 166	pluripatológico
T8	DISO 198 222	diabetes mellitus tipo 2
#5	AnnotatorNotes T8	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T9	Duration 226 232	8 años
T10	DISO 248 269	hipertensión arterial
#6	AnnotatorNotes T10	C0020538; Hypertensive disease; Disease or Syndrome
T11	Duration 273 287	más de 10 años
T12	DISO 303 313	dislipemia
#7	AnnotatorNotes T12	C0242339; Dyslipidemias; Disease or Syndrome
T13	DISO 316 341	isquemia arterial crónica
T14	Duration 334 341	crónica
T15	PROC 351 362	Tratamiento
T16	CHEM 388 398	metformina
#8	AnnotatorNotes T16	C0025598; metformin; Organic Chemical · Pharmacologic Substance
T17	Dose 399 404	850mg
T18	CHEM 407 417	gliclazida
#9	AnnotatorNotes T18	C0017631; gliclazide; Organic Chemical · Pharmacologic Substance
T19	Dose 418 422	30mg
T20	CHEM 425 434	enalapril
#10	AnnotatorNotes T20	C0014025; enalapril; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T21	CHEM 435 452	hidroclorotiazida
#11	AnnotatorNotes T21	C0020261; hydrochlorothiazide; Organic Chemical · Pharmacologic Substance
T22	Dose 453 462	20/12,5mg
T23	CHEM 465 487	ácido acetilsalicílico
#12	AnnotatorNotes T23	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T24	Dose 488 493	100mg
T25	CHEM 496 506	cilostazol
#13	AnnotatorNotes T25	C0055729; cilostazol; Organic Chemical · Pharmacologic Substance
T26	Dose 507 511	10mg
T27	Neg_cue 542 544	No
T28	Negated 545 552	refiere
T29	PROC 567 585	Exploración física
#14	AnnotatorNotes T29	C0031809; Physical Examination; Health Care Activity
T30	Observation 610 620	consciente
#15	AnnotatorNotes T30	C0229994; Conscious mind; Mental Process | C0234421; Conscious; Mental Process
T31	Observation 623 632	orientado
T32	ANAT 670 681	mucocutánea
#16	AnnotatorNotes T32	C4516595; Entire skin and mucous membrane; Body System
T33	PROC 684 686	TA
T34	PROC 701 706	Talla
T35	PROC 715 719	Peso
T36	PROC 728 731	IMC
T37	PROC 740 763	Pruebas complementarias
#17	AnnotatorNotes T37	C1515980; Ancillary Study; Research Activity
T38	PROC 765 774	Hemograma
#18	AnnotatorNotes T38	C0009555; Complete Blood Count; Laboratory Procedure | C0200631; Complete blood count without differential; Laboratory Procedure | C0852571; Blood counts NEC; Laboratory Procedure
T39	PROC 777 787	bioquímica
#19	AnnotatorNotes T39	C0201682; Chemical procedure; Laboratory Procedure | C0430027; biochemical test; Laboratory Procedure
T40	PROC 813 820	Glucosa
T41	PROC 833 849	colesterol total
#20	AnnotatorNotes T41	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T42	PROC 861 875	colesterol LDL
#21	AnnotatorNotes T42	C0202117; Low density lipoprotein cholesterol measurement; Laboratory Procedure
T43	Neg_cue 876 878	no
T44	Negated 879 889	calculable
T45	PROC 892 906	colesterol HDL
#22	AnnotatorNotes T45	C0392885; High density lipoprotein measurement; Laboratory Procedure
T46	PROC 917 930	triglicéridos
#23	AnnotatorNotes T46	C0202236; Triglycerides measurement; Laboratory Procedure
T47	PROC 942 965	Hemoglobina glicosilada
#24	AnnotatorNotes T47	C0202054; Glucohemoglobin measurement; Laboratory Procedure
T48	Neg_cue 979 982	sin
T49	DISO 983 995	alteraciones
#25	AnnotatorNotes T49	C0012634; Disease; Disease or Syndrome
T50	Negated 983 995	alteraciones
T51	PROC 1009 1020	TRATAMIENTO
#26	AnnotatorNotes T51	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T52	PROC 1038 1056	ajusta tratamiento
T53	CHEM 1070 1081	dulaglutida
#27	AnnotatorNotes T53	C3179549; dulaglutide; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T54	CHEM 1100 1107	fármaco
#28	AnnotatorNotes T54	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T55	LIVB 1111 1119	paciente
#29	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Neg_cue 1206 1214	abandona
T57	Negated 1215 1222	tóxicos
T58	Frequency 1263 1269	diaria
T59	DISO 1297 1348	Diabetes Mellitus tipo 2 con mal control metabólico
#30	AnnotatorNotes T59	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T60	DISO 1350 1369	Síndrome metabólico
#31	AnnotatorNotes T60	C0524620; Metabolic Syndrome X; Disease or Syndrome
T61	Frequency 88 93	anual
T62	PROC 556 562	EXAMEN
T63	PROC 1273 1284	DIAGNÓSTICO
T64	Quantifier_or_Qualifier 342 347	GIIIb
T65	Observation 589 608	Buen estado general
T66	Observation 634 652	eupneico en reposo
T67	Observation 654 681	normocoloración mucocutánea
T68	Result_or_Value 687 698	145/80 mmHg
T69	Result_or_Value 707 712	1.70m
T70	Result_or_Value 720 725	98 kg
T71	Result_or_Value 732 736	33.9
T72	Result_or_Value 821 830	226 mg/dl
T73	Result_or_Value 850 858	248mg/dl
T74	Quantifier_or_Qualifier 879 889	calculable
T75	Result_or_Value 907 914	42mg/dl
T76	Result_or_Value 931 939	449mg/dl
T77	Result_or_Value 966 970	8.8%
T78	Observation 1165 1189	aumento de su motivación
T79	Observation 1206 1222	abandona tóxicos
T80	Observation 1224 1236	mejora dieta
T81	Observation 1326 1348	mal control metabólico
T82	Patient 21 29	Paciente
T83	Patient 133 138	Varón
T84	History_of 198 222	diabetes mellitus tipo 2
T85	History_of 248 269	hipertensión arterial
T86	History_of 303 313	dislipemia
T87	History_of 316 341	isquemia arterial crónica
T88	Patient 1111 1119	paciente
T90	Observation 1239 1262	inicia actividad física
#32	AnnotatorNotes T81	Chronic disease - poor control (C0421179) Semantic Types: Finding
T89	Observation 1128 1143	pérdida de peso
